What Happened?
Houston, TX-based Coya Therapeutics Appointed Gregory MacMichael as Chief Technical Officer
About the Company
The company`s proprietary CTreg™ (cryopreservation for Tregs) system is the first in the industry to create an `off the shelf` approach to Treg cell therapy allowing for serial infusions. Through our patented TAI™ (Tregs Against Inflammation) and EAI™ (Exosomes Against Inflammation) platforms , Coya is focused on the advancement of disease modifying approaches to address the significant unmet medical needs of patients with ALS, Parkinson`s, Alzheimer`s, FTD and autoimmune diseases.
About the Person
Gregory MacMichael is Chief Technical Officer at Coya Therapeutics. Previously, Gregory held various senior IT leadership roles in the industry.
Info Source
News
Short Profile